Thus it can be concluded from the present study that anti-HBc IgG could frequently be the only marker for past HBV infection and its presence should be tested in all patients of CLD as patients with isolated anti-HBc IgG positivity can develop liver disease. This evidence concerns the gene KRT88P and liver disorder.